本文選題：阿司匹林 + 冠心病�。� 參考：《天津醫(yī)科大學(xué)》2015年碩士論文

【摘要】：目的:分析冠心病患者OPCAB術(shù)前使用阿司匹林的風(fēng)險(xiǎn)和獲益,并進(jìn)一步分析阿司匹林在老年患者中的應(yīng)用。方法:采用回顧性隊(duì)列研究。選取2010年1月~2014年6月天津市胸科醫(yī)院連續(xù)首次擇期OPCAB手術(shù)病例。依據(jù)術(shù)前5天內(nèi)使用阿司匹林情況分為兩組,通過(guò)單因素和傾向指數(shù)回歸分析方法比較兩組患者術(shù)后住院期間預(yù)后的差異。進(jìn)一步選取其中65歲以上患者,使用相同方法比較兩組老年患者預(yù)后。通過(guò)對(duì)早期預(yù)后的比較,評(píng)價(jià)OPCAB患者術(shù)前使用阿司匹林的風(fēng)險(xiǎn)和獲益。結(jié)果:總計(jì)納入患者3531例,其中男性2564例,女性967例,平均年齡63.2(±8.5)歲。持續(xù)使用阿司匹林至術(shù)前5天內(nèi)817例,術(shù)前停用阿司匹林5天及以上2714例。全組患者術(shù)后院內(nèi)死亡29例。通過(guò)傾向指數(shù)回歸分析,術(shù)前5天內(nèi)服用阿司匹林與停藥相比,住院期間全因死亡率(校正OR0.89,95%CI0.35-2.26,P=0.80)、術(shù)后心肌梗死(校正OR0.52,95%CI0.15-1.81,P=0.31)、腦血管意外(校正OR 1.06,95%CI0.32-3.49,P=0.93)、腎衰(校正OR0.86,,95%CI0.40-1.84,P=0.70)、血液透析(校正OR0.66,95%CI0.12-2.68,P=0.48),開(kāi)胸止血(校正OR0.79,95%CI0.46-1.36,P=0.40),差異無(wú)統(tǒng)計(jì)學(xué)意義,而服用阿司匹林組術(shù)后輸紅細(xì)胞比例較高(校正OR1.39,95%CI1.16-1.66,P0.01)。老年患者(65歲)中,通過(guò)傾向指數(shù)回歸分析,術(shù)前5天內(nèi)服用阿司匹林與停藥相比,住院期間全因死亡率(校正OR0.53,95%CI0.15-1.95,P=0.34)、術(shù)后心肌梗死(校正OR0.32,95%CI0.04-2.62,P=0.29)、腦血管意外(校正OR 1.30,95%CI0.24-6.91,P=0.76)、腎衰(校正OR0.53,,95%CI0.17-1.65,P=0.27)、血液透析(校正OR0.42,95%CI0.05-3.38,P=0.44),開(kāi)胸止血(校正OR0.57,95%CI0.41-1.87,P0.01)差異無(wú)統(tǒng)計(jì)學(xué)意義,同樣,服用阿司匹林組紅細(xì)胞輸血比例較高(校正OR1.50,95%CI1.13-2.00,P0.01)。結(jié)論:1.OPCAB術(shù)前5天內(nèi)使用阿司匹林會(huì)增加紅細(xì)胞輸注,沒(méi)有增加二次開(kāi)胸止血的發(fā)生率。2.OPCAB術(shù)前5天內(nèi)使用阿司匹林與術(shù)后早期死亡率、早期心肌梗死、腦血管意外、腎衰和透析等發(fā)生率無(wú)相關(guān)性。3.老年(65歲)患者OPCAB術(shù)前5天內(nèi)使用阿司匹林會(huì)增加紅細(xì)胞輸注,沒(méi)有增加二次開(kāi)胸止血的發(fā)生率。4.老年(65歲)患者OPCAB術(shù)前5天內(nèi)使用阿司匹林與術(shù)后早期死亡率、早期心肌梗死、腦血管意外、腎衰和血液透析等發(fā)生率無(wú)相關(guān)性。5.上述研究結(jié)論有待大規(guī)模隨機(jī)對(duì)照臨床試驗(yàn)進(jìn)一步證實(shí)。
[Abstract]:Aim: to analyze the risk and benefit of aspirin use in patients with coronary heart disease (CHD) before OPCAB, and to further analyze the use of aspirin in elderly patients. Methods: retrospective cohort study was used. From January 2010 to June 2014, we selected the first consecutive elective OPCAB operation in Tianjin chest Hospital. The patients were divided into two groups according to the use of aspirin within 5 days before operation. The prognosis of the two groups during hospitalization was compared by univariate and tendency index regression analysis. Patients over 65 years of age were further selected to compare the prognosis of the two groups with the same method. To evaluate the risk and benefit of aspirin use in patients with OPCAB before operation by comparing early prognosis. Results: a total of 3531 patients were included, including 2564 males and 967 females, with an average age of 63.2 (鹵8.5) years. There were 817 patients who continued to use aspirin for 5 days before operation and 2714 patients who stopped using aspirin for 5 days or more before operation. 29 patients died in hospital after operation. By regression analysis of propensity index, aspirin was taken within 5 days before operation compared with withdrawal. Total mortality rate during hospitalization (corrected OR0.8995 CI0.35-2.26 P0.80, postoperative myocardial infarction (corrected OR0.5295 CI 0.15-1.81 P0.31), cerebrovascular accident (OR 1.0695 CI 0.32-3.49 P0.93), renal failure (corrected OR0.8695 CI0.40-1.84P 0.70), hemodialysis (corrected OR0.6695CI0.12-2.68 Pnu 0.48), thoracotomy and hemostasis (corrected OR0.7995 CI0.46-1.36 P0.40), no statistical significance. In aspirin group, the ratio of red blood cell transfusion was higher (corrected OR 1.39 ~ 95CI 1.16-1.66C P 0.01). In elderly patients (65 years old), the tendency index regression analysis showed that aspirin intake within 5 days before operation was compared with withdrawal. Total mortality rate during hospitalization (adjusted OR0.5395 CI0.15-1.95CI0.34), postoperative myocardial infarction (corrected OR0.32m95 CI0.04-2.62P0.29, cerebrovascular accident (OR 1.3095 CI 0.24-6.91P0.76), renal failure (corrected OR0.5395CI0.17-1.65P0.27), hemodialysis (corrected OR0.4295CI5-3.38Pl 0.44), thoracotomy and hemostasis (corrected OR0.5795 CI0.41-1.87 P0.01) had no statistical significance, the same was true. The proportion of red blood cell transfusion was higher in aspirin group (corrected OR 1.50 ~ 95CI 1.13-2.00 P 0.01). Conclusion: 1. The use of aspirin within 5 days before OPCAB can increase the red blood cell infusion, but not the incidence of secondary thoracotomy and hemostasis. 2. Before OPCAB, aspirin use within 5 days before operation and early postoperative mortality, early myocardial infarction, cerebrovascular accident, and so on. There was no correlation between renal failure and dialysis. Aspirin increased erythrocyte infusion within 5 days before OPCAB, but did not increase the incidence of secondary thoracotomy hemostasis. There was no correlation between aspirin use and postoperative early mortality, early myocardial infarction, cerebrovascular accident, renal failure and hemodialysis. These conclusions need to be further confirmed in a large-scale randomized controlled clinical trial.
【學(xué)位授予單位】：天津醫(yī)科大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2015
【分類(lèi)號(hào)】：R654.2

【共引文獻(xiàn)】

相關(guān)期刊論文 前5條

1 單守杰;陳紹良;劉志忠;張俊杰;葉飛;林松;田乃亮;;血管內(nèi)超聲指導(dǎo)對(duì)于冠狀動(dòng)脈真性分叉病變介入治療長(zhǎng)期預(yù)后的影響[J];嶺南心血管病雜志;2013年06期

2 林曉強(qiáng);朱海;詹源勝;;成功開(kāi)通慢性完全閉塞冠狀動(dòng)脈病變血管能提高患者的生存率[J];心臟雜志;2013年06期

3 楊威;凌云鵬;陳生龍;陳_g;;國(guó)人非體外循環(huán)冠狀動(dòng)脈旁路移植術(shù)前阿司匹林治療策略分析[J];中國(guó)胸心血管外科臨床雜志;2015年01期

4 李俊紅;艾克拜爾;木拉提;艾克熱木;;冠狀動(dòng)脈旁路移植術(shù)前不停用阿司匹林抗血小板治療有效性和安全性的Meta分析[J];中國(guó)循環(huán)雜志;2015年06期

5 Javier Salmerón;Carmen Vinaixa;Rubén Berenguer;Juan Manuel Pascasio;Juan José Sánchez Ruano;Miguel ángel Serra;Ana Gila;Moisés Diago;Manuel Romero-Gómez;José María Navarro;Milagros Testillano;Conrado Fernández;Dolores Espinosa;Isabel Carmona;José Antonio Pons;Francisco Jorquera;Francisco Javier Rodriguez;Ramón Pérez;José Luis Montero;Rafael Granados;Miguel Fernández;Ana Belén Martín;Paloma Mu?oz de Rueda;Rosa Quiles;;Effectiveness and safety of first-generation protease inhibitors in clinical practice:Hepatitis C virus patients with advanced fibrosis[J];World Journal of Gastroenterology;2015年30期

相關(guān)會(huì)議論文 前1條

1 林曉強(qiáng);朱海;詹源勝;;成功開(kāi)通慢性完全閉塞冠狀動(dòng)脈病變血管能提高患者的生存率[A];全國(guó)第十三屆心臟學(xué)會(huì)、第十六屆心功能專(zhuān)業(yè)委員會(huì)和《心臟雜志》編委會(huì)聯(lián)合學(xué)術(shù)大會(huì)會(huì)議紀(jì)要[C];2013年

相關(guān)博士學(xué)位論文 前2條

1 王堅(jiān);非體外循環(huán)下冠狀動(dòng)脈旁路移植術(shù)后橋通暢率和肺栓塞的臨床研究[D];北京協(xié)和醫(yī)學(xué)院;2014年

2 肖付誠(chéng);術(shù)前持續(xù)服用阿司匹林及序貫旁路移植術(shù)對(duì)非體外循環(huán)冠狀動(dòng)脈旁路移植術(shù)早、中期臨床結(jié)局的影響[D];北京協(xié)和醫(yī)學(xué)院;2015年

相關(guān)碩士學(xué)位論文 前4條

1 蔡懷卿;非體外循環(huán)冠狀動(dòng)脈旁路移植術(shù)患者凝血功能變化的實(shí)驗(yàn)研究[D];北京協(xié)和醫(yī)學(xué)院;2013年

2 高淅;電針預(yù)處理對(duì)老年冠心病患者非心臟手術(shù)的心臟保護(hù)作用[D];第四軍醫(yī)大學(xué);2013年

3 劉穎;冠脈搭橋術(shù)后復(fù)發(fā)心絞痛患者冠脈造影特點(diǎn)及橋血管病變相關(guān)危險(xiǎn)因素分析[D];天津醫(yī)科大學(xué);2013年

4 王肇;不同抗血小板方案對(duì)冠狀動(dòng)脈旁路移植術(shù)后遠(yuǎn)期橋血管通暢率和預(yù)后的影響[D];中國(guó)人民解放軍醫(yī)學(xué)院;2014年

，

本文編號(hào)：1824698